HealthCap VII L.P. 13D and 13G filings for Fusion Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-03-20 6:08 pm Unchanged | 2024-03-18 | 13D | Fusion Pharmaceuticals Inc. FUSN | HealthCap VII L.P. | 3,807,247 4.500% | 0 (Unchanged) | Filing |
2024-03-07 4:05 pm Unchanged | 2024-03-07 | 13D | Fusion Pharmaceuticals Inc. FUSN | HealthCap VII L.P. | 3,807,247 5.300% | 0 (Unchanged) | Filing |
2023-03-06 4:06 pm Unchanged | 2023-02-16 | 13D | Fusion Pharmaceuticals Inc. FUSN | HealthCap VII L.P. | 3,807,247 6.100% | 0 (Unchanged) | Filing |
2020-07-10 5:00 pm Purchase | 2020-06-30 | 13D | Fusion Pharmaceuticals Inc. FUSN | HealthCap VII L.P. | 3,807,247 9.100% | 3,807,247![]() (New Position) | Filing |